Active ingredientDovitinibCat. No. P-D178-001CAS 405169-16-6Family · Pharmaceutical analytical standards
Dovitinib
An investigational oral inhibitor of many receptor tyrosine kinases at once, including FGFR 1, 2 and 3, VEGFR and PDGFR: it was studied in several tumours, from breast to kidney, reaching phase 3 in metastatic renal cell carcinoma in 2011, without being approved. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Chemically it is a benzimidazole-quinolinone: it contains the benzimidazole ring, one of the most widely used in medicines and found in nature in vitamin B12, where it helps hold the cobalt atom.
Go to the active ingredient →Active ingredientDovitinibCat. No. P-D178-001CAS 405169-16-6
Isotopically labelledDovitinib-d8Cat. No. P-D178-002
Isotopically labelledN-Desmethyl Dovitinib-d8Cat. No. P-D178-003CAS 1246814-93-6
ImpurityN-Desmethyl DovitinibCat. No. P-D178-004CAS 668432-44-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.